Wells Fargo & Company MN Raises Holdings in Rapport Therapeutics (NASDAQ:RAPP)
Wells Fargo & Company MN raised its stake in Rapport Therapeutics (NASDAQ:RAPP – Free Report) by 38.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,824 shares of the company’s stock after purchasing an additional 1,352 shares during the period. Wells Fargo […]
Wells Fargo & Company MN raised its stake in Rapport Therapeutics (NASDAQ:RAPP – Free Report) by 38.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,824 shares of the company’s stock after purchasing an additional 1,352 shares during the period. Wells Fargo […]
